W&M GOP Bills Would Incentivize Infectious Disease Drug Development

By Kelly Lienhard / July 8, 2020 at 7:54 PM
Republican lawmakers on the House Ways & Means Committee will soon introduce four bills aimed at providing additional incentives and tax benefits for pre-revenue companies, start-up businesses and partnerships that are focused on infectious disease drug development, committee staff members told reporters on a press call Wednesday (July 8). The lawmakers plan to introduce the bills Thursday (July 9), in time for inclusion in the COVID-19 relief package that’s expected to be introduced at the end of this month. GOP...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.